Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29557173 | 0.94 | LMNA (0.43) | LMNAHPGDALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL28774875 | 0.94 | LMNA (0.43) | LMNAHPGDALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL11874229 | 0.91 | LMNA (0.47) | LMNAHPGDALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL4311751 | 0.85 | LMNA (0.47) | LMNAHPGDALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL708587 | 0.84 | ALDH1A1 (0.42) | LMNAHPGDALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL10878856 | 0.84 | HPGD (0.47) | LMNAHPGDALDH1A1TSHRSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL1020768 | 0.83 | LMNA (0.46) | LMNAHPGDALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL30480271 | 0.83 | LMNA (0.72) | LMNAHPGDALDH1A1SMN1; SMN2CYP2C19 | |
| SCHEMBL12217873 | 0.83 | LMNA (0.72) | LMNAHPGDALDH1A1SMN1; SMN2CYP2C19 | |
| SCHEMBL9456178 | 0.82 | TSHR (0.38) | LMNATSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119569600-A | New preparation method of iopromide | 重庆常捷医药有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-118930450-A | Method for preparing iopromide and purifying intermediate | 重庆煜洋药业有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-116354843-B | Method for synthesizing iopromide | 重庆圣华曦药业股份有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-116354843-A | Improved method for synthesizing iopromide and application of iopromide in injection | 重庆圣华曦药业股份有限公司 | 2023-06-30 | — | — | CN | claimed |
| CN-119569600-A | New preparation method of iopromide | 重庆常捷医药有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119569600-A | New preparation method of iopromide | 重庆常捷医药有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-118930450-A | Method for preparing iopromide and purifying intermediate | 重庆煜洋药业有限公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-116354843-B | Method for synthesizing iopromide | 重庆圣华曦药业股份有限公司 | 2024-11-01 | — | — | CN | disclosed |
| CN-116354843-B | Method for synthesizing iopromide | 重庆圣华曦药业股份有限公司 | 2024-11-01 | — | — | CN | disclosed |
| CN-116354843-A | Improved method for synthesizing iopromide and application of iopromide in injection | 重庆圣华曦药业股份有限公司 | 2023-06-30 | — | — | CN | disclosed |
| CN-116354843-A | Improved method for synthesizing iopromide and application of iopromide in injection | 重庆圣华曦药业股份有限公司 | 2023-06-30 | — | — | CN | disclosed |
| CN-105636933-B | The method for preparing the intermediate of Iopromide | 大熊制药株式会社 | 2017-12-15 | — | — | CN | disclosed |
| EP-0619744-A1 | NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS | MALLINCKRODT MEDICAL, INC. (US) | 1994-10-19 | — | — | EP | disclosed |
| WO-1994005337-A1 | NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS | MALLINCKRODT MEDICAL, INC. (US) | 1994-03-17 | — | — | WO | disclosed |
| WO-1993010825-A1 | NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS | MALLINCKRODT MEDICAL, INC. (US) | 1993-06-10 | — | — | WO | disclosed |
| US-5191120-A | Process for preparing nonionic X-ray contrast agents | MALLINCKRODT MEDICAL, INC. (US) | 1993-03-02 | — | — | US | disclosed |
| EP-0504266-A1 | NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS | MALLINCKRODT, INC. (US) | 1992-09-23 | — | — | EP | disclosed |
| US-5075502-A | NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS | MALLINCKRODT, INC. (US) | 1991-12-24 | — | — | US | disclosed |
| WO-1991009007-A2 | NONIONIC X-RAY CONTRAST AGENTS, COMPOSITIONS AND METHODS | MALLINCKRODT, INC. (US) | 1991-06-27 | — | — | WO | disclosed |
| US-4364921-A | RADIOPACITY | SCHERING, AKTIENGESELLSCHAFT (DE) | 1982-12-21 | — | — | US | disclosed |